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INTRODUCTION:  Inﬂammatory  myositis  as  a  paraneoplastic  presentation  of  gallbladder  cancer  is an
extremely  rare event.  In  this  paper  we reported  the  ﬁrst  case  of  gallbladder  carcinoma  presented  as
polymyositis.
PRESENTATION  OF  CASE:  A  68-year-old  housewife  presented  with  proximal  muscles  weakness,  pain,  sig-
niﬁcant  decrease  in  force  of  proximal  muscles,  and globally  decreased  deep  tendon  reﬂexes.  Laboratory
studies  revealed  an  anemia,  increased  acute  phase  reactants  and  increased  serum  creatine  phospho-
kinase  (CPK)  levels.  Electromyography  (EMG)  and  nerve  conduction  velocity  test  (NCV)  demonstrated
mild  myopathic  changes.  Muscle  biopsy  was  suggestive  for polymyositis.  Corticosteroid  therapy  initi-
ated  and  a meticulous  search  for  probable  underlying  malignancy  performed  concurrently.  Malignancy
workup  ﬁnally  revealed  a gallbladder  tumor.  Patient  candidated  for extended  cholecystectomy.  Patho-
logic  evaluation  of gallbladder  tumor  demonstrated  a moderately  differentiated  carcinoma.  Progressive
improvement  in clinical  conditions  and  complete  normalization  of  laboratory  parameters  occurred  post-
operatively.  After  8 months  of  follow-up  patient  is  still  alive  and  in good  state  of health.  There  is no
evidence  of metastatic  or local  recurrence  of  tumor.  Musculoskeletal  complaints  subsided  completely.
DISCUSSION: Gallbladder  carcinoma  is a rare  and  usually  aggressive  malignancy.  Its  primary  presenta-
tion  by  paraneoplastic  syndromes  especially  in  the  form  of  paraneoplastic  neurological  syndromes  is an
extremely  rare event.  Some  believes  that  increased  association  between  inﬂammatory  myopathy  and
malignancy  is limited  to  the  dermatomyositis;  however,  presentation  of  our  patient  as  polymyositis  is
contrary  to  this. This  is the  ﬁrst  reported  case  of gallbladder  cancer  who  presented  with  polymyositis.
CONCLUSION: Gallbladder  cancer  though  rare,  should  be considered  in patients  with  inﬂammatory  myosi-
tis.
gical © 2013 Sur
. Introduction
Inﬂammatory myositis (including dermatomyositis/
olymyositis) is an inﬂammatory myopathy which accompa-
ied by muscle weakness as its hallmark symptom. This condition
s associated with malignancies in a signiﬁcant minority of cases.
n association between malignancy and inﬂammatory myopathy
as been suspected as early as 1916, when Stertz reported the
imultaneous occurrences of PM and gastric carcinoma.1 The
lose relationship between inﬂammatory myopathy and cancer
s consistent with the concept that paraneoplastic processes
inked to oncogenesis and autoimmunity contribute to the disease
n a subset of these cases. However, the precise links between
alignancy and inﬂammatory myopathy remain incompletely
nderstood.2,3
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This case report presented a gallbladder carcinoma manifested
as polymyositis, which is to our knowledge the fourth known
case in the world of this malignancy associated with inﬂammatory
myopathy despite the previous three cases presented by dermato-
myositis; this is the ﬁrst reported case of gallbladder carcinoma
which was  associated with polymyositis.
2. Case presentation
A  68 year old housewife presented with proximal muscles weak-
ness and pain since two  weeks prior to admission. Patient had no
previous history of similar problem and/or hospitalization due to
any medical or surgical condition. On examination, there was a sig-
niﬁcant decrease in force of proximal muscles of both upper and
lower extremities which was  more prominent in upper limbs. Prox-
Open access under CC BY-NC-ND license. imal muscle tenderness was also notable. However, distal muscles
had a relatively normal force. Deep tendon reﬂexes were decreased
globally. There was no other signiﬁcant physical ﬁnding on exami-
nation.
Y-NC-ND license. 
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this. It should be noted that this is the ﬁrst reported case of gallblad-Fig. 1. Macroscopic appearance of the specimen (gallbladder tumor).
Initial laboratory studies indicated a normocytic hypochromic
nemia associated with leukocytosis and mild thrombocytopenia.
erum CPK level was 22,250 IU/L (normal up to 170). Acute phase
eactants including the erythrocyte sedimentation rate (ESR) and
-reactive protein (CRP) levels were also increased. Other abnor-
al ﬁndings included increased aspartate aminotransferase (AST),
lanine aminotransferase (ALT), Lactate dehydrogenase (LDH) and
riglyceride levels; and decreased total protein, albumin, calcium,
igh-density lipoprotein (HDL) and Low-density lipoprotein (LDL)
holesterol levels.
Thyroid  function, renal function, bilirubin, alkaline phosphatase
nd immune markers including anti-nuclear antibody (ANA), anti
ouble stranded deoxytribonucleic acid (Anti ds-DNA), anti-cyclic
itrullinated peptide antibody (anti-CCP), and anti JO-1 antibody
ere all within normal limits. Serum viral hepatitis markers were
lso negative (Fig. 1).
EMG/NCV  study demonstrated mild myopathic changes.
Patient underwent muscle biopsy which revealed inﬂamma-
ory myopathy, which was reported most probably suggestive for
olymyositis (Figs. 2 and 3).
Corticosteroid therapy initiated with 60 mg  Prednisolon
1 mg/kg) in divided daily doses and a meticulous search for prob-
ble underlying malignancy performed concurrently. Malignancy
orkup ﬁnally revealed a gallbladder tumor with increased level of
arcinoembryonic antigen (CEA) and normal level of cancer antigen
CA) 19-9 and CA 125.
The  patient candidated for surgical intervention and extended
holecystectomy with abdominal sampling undertaken. Pathologic
valuation of gallbladder tumor demonstrated a moderately differ-
ntiated carcinoma which was at least in stage IIA (Figs. 4–8) and
bdominal samples were negative for malignancy.
Corticosteroid therapy continued postoperatively for 10 days
ith pre-operative dose and then gradually corticosteroid
ecreased to 5 mg/day within 2 weeks and discharged home with
his dose and prednisolone subsequently discontinued 1 month
fter discharge.
Patient responded well to the surgery and a progressive
mprovement in clinical condition and complete normalization of
aboratory parameters observed. Upper extremity muscular force
t discharge was 4/5 and force of lower limb was 5/5. It should
e noted that, a common bile duct (CBD) stone complicated the
ost-operative recovery course of the patient, which managed
ndoscopically.
After 8 months of post-operative follow-up, patient is still alive
nd in good state of health. There is no evidence of metastatic orFigs. 2 and 3. Microscopic feature of polymiositis.
local recurrence of tumor and musculoskeletal complaints subsided
completely.
3. Discussion
Gallbladder carcinoma is a rare and usually aggressive malig-
nancy that occurs predominantly in the elderly4 and its primary
presentation by paraneoplastic syndromes especially in the form
of paraneoplastic neurological syndromes (PNS) is an extremely
rare event. PNS are deﬁned as remote cancer effects which are nei-
ther due to tumoral invasion or its metastasis nor due to ischemic,
metabolic, infectious, nutritional or therapeutic consequences of
the primary tumor.5,6 Any level of central or peripheral nervous
system including neuromuscular junction and muscle may  be
affected in PNS.6 Inﬂammatory myopathies are well known PNSs
and are most commonly associated with ovarian cancer, lung can-
cer, breast cancer, melanoma, colorectal cancer and non-Hodgkin’s
lymphoma.6,7 Estimates of the associated risk of malignancy
with inﬂammatory myopathies vary widely in different studies
(between 6 and 60).8
Some believes that increased association between inﬂamma-
tory myopathy and malignancy is limited to the dermatomyositis7;
however, presentation of our patient as polymyositis is contrary toder cancer who presented with polymyositis. In all other cases of
myopathic presentations of gallbladder cancer which include only
3 published reports, patients presented with dermatomyositis.9–11
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Figs. 4–8. Microscopic appearance of gallbladder adenocarcinoma.
s
CIn conclusion, gallbladder cancer though rare, but should be con-
idered in patients with both dermatomyositis and polymyositis.onﬂicts of interest
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